Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;18(2):401-12.
doi: 10.3233/JAD-2009-1154.

Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies

Mikko Hiltunen  1 , Thomas van Groen, Jukka Jolkkonen
Affiliations
Review

Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies

Mikko Hiltunen et al. J Alzheimers Dis. 2009.

Abstract

Amyloid-beta (Abeta) has remained a central feature in research into Alzheimer's disease (AD). Yet the function of the amyloid-beta protein precursor (AbetaPP) and its processing products in the central nervous system is controversial. This review examines experimental literature from cell cultures to transgenic AD and brain injury models with a special emphasis on the functional role of AbetaPP and AbetaPP-derived peptides. AbetaPP knock-out mice exhibit severe metabolic abnormalities and behavioral deficits, indicating an important physiological function of AbetaPP. Also, an increasing body of evidence suggests that while Abeta is undoubtedly linked to neurodegeneration, the soluble amino-terminal fragment of AbetaPP (sAbetaPPalpha) has neuroprotective, neurotrophic, and cell adhesive functions. Moderate overexpression of human AbetaPP in rodents does not produce apparent Abeta pathology and has no significant effect on cognitive or sensorimotor behavior and, surprisingly, may even provide histological neuroprotection against focal cerebral ischemia. In contrast, phenotypes with more severe Abeta pathology show impaired cognitive performance, increased vulnerability to brain ischemia and trauma, and less favorable functional outcome even before Abeta deposition. A delicate balance in AbetaPP processing seems to determine its functional consequences. Thus, it is tempting to speculate that promotion of alpha-secretase-mediated cleavage of AbetaPP, which leads to increased sAbetaPPalpha production, provides a novel therapeutic strategy in the treatment of AD and brain injury.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

MeSH terms

Substances

LinkOut - more resources